Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

por Patti, Francesco, Penaherrera, Javier Nicolas, Zieger, Lorissa, Wicklein, Eva-Maria
Publicado 2021

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure

por Hellwig, Kerstin, Duarte Caron, Fernando, Wicklein, Eva-Maria, Bhatti, Aasia, Adamo, Alessandra
Publicado 2020

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT(®) Autoinjector: A Retrospective Cohort Study

por Butler, Oisín, Heeg, Simone, Holl, Katsiaryna, Frenz, Ann-Kathrin, Wicklein, Eva-Maria, Rametta, Mark, Yeo, Sandy
Publicado 2021

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

por Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Publicado 2016